SEARCH

SEARCH BY CITATION

References

  • 1
    Poupon R, Chretien Y, Poupon RE, Ballet F, Calmus Y, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; I(8537): 834836.
  • 2
    David R, Kurtz W, Strohm DW, Leuschner U. Die Wirkung von Ursodeoxycholsaeure bei chronischen Lebererkrankungen. Eine Pilotstudie. Z Gastroenterologie 1985; 23: 240.
  • 3
    Poupon RE, Balkau B, Eschwege E, Poupon R, the UDCA-PBC Study Group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. New Engl J Med 1991; 324: 15481554.
  • 4
    Heathcote EJ, Cauch-Dudek K, Walter V, Bailey RJ, Blendis LM, Ghent CN, et al. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. HEPATOLOGY 1994; 19: 11491156.
  • 5
    Lindor DL, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 12841290.
  • 6
    Combes B, Carithers RL Jr, Maddrey WB, Lin D, McDonald MF, Wheeler DE, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. HEPATOLOGY 1995; 22: 759766.
  • 7
    Kaplan MM, Knox TZ, Arora S. Primary biliary cirrhosis treated with low-dose oral pulse methotrexate. Ann Intern Med 1998; 109: 429431.
  • 8
    Kaplan MM. Methotrexate treatment of chronic cholestatic liver disease: friend or foe. Quart J Med 1989; 268: 757761.
  • 9
    Kaplan MM, Knox TA. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. Gastroenterology 1991; 101: 13321338.
  • 10
    Bergasa NV, Jones A, Kleiner DE, Rabin L, Park Y, Wells MC, et al. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis. Am J Gastroenterol 1996; 91: 295299.
  • 11
    Buscher HP, Zietzschmann Y, Gerok W. Positive response to methotrexate and ursodeoxy-cholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. J Hepatol 1993; 18: 914.
  • 12
    Lindor KD, Dickson ER, Jorgensen RA, Anderson ML, Wiesner RH, Gores GJ, et al. The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study. HEPATOLOGY 1995; 22: 11581162.
  • 13
    Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchow's Arch A 1978; 379: 103112.
  • 14
    HosmerDWJr, LemeshowS, eds. Applied Survival Analysis: Regression Modeling of Time to Event Data. Hoboken, NJ: Wiley, 1999.
  • 15
    Cox DR. Regression models and life tables (with discussion). J Royal Statistical Society 1972; B34: 187220.
  • 16
    Emerson SS, Fleming TR. Symmetric group sequential designs. Biometrics 1989; 45: 905923.
  • 17
    Burington BE, Emerson SS. Flexible implementation of group sequential stopping rules using constrained boundaries. Biometrics 2003; 59: 770777.
  • 18
    Emerson SS, Fleming TR. Parameter estimation following group sequential hypothesis testing. Biometrika 1990; 77: 875892
  • 19
    Sharma A, Provenzale D, McKusick A, Kaplan MM. Interstitial pneumonitis after low dose methotrexate therapy in primary biliary cirrhosis. Gastroenterology 1994; 107: 266270.
  • 20
    Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile; simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res 1987; 28: 589595.
  • 21
    Van Steenbergen W, Sciot R, Van Euken P, Desmet V, Fevery J. Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis. Acta Clin Belgica 1996; 51: 818.
  • 22
    Gonzalez-Koch A, Brahm J, Antezana C, Smok G, Cumsille MA. The combination of ursodeoxy-cholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone. J Hepatol 1997; 27: 143149.